DI CESARE MANNELLI, LORENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.105
EU - Europa 22.298
AS - Asia 11.640
SA - Sud America 2.045
AF - Africa 338
OC - Oceania 163
Continente sconosciuto - Info sul continente non disponibili 3
Totale 61.592
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.785
PL - Polonia 10.506
RU - Federazione Russa 5.350
SG - Singapore 3.138
CN - Cina 2.661
IT - Italia 1.901
HK - Hong Kong 1.888
BR - Brasile 1.672
VN - Vietnam 1.451
IE - Irlanda 1.274
KR - Corea 893
SE - Svezia 839
FI - Finlandia 579
FR - Francia 505
DE - Germania 446
IN - India 392
GB - Regno Unito 338
ID - Indonesia 277
CA - Canada 173
AR - Argentina 157
JP - Giappone 156
AU - Australia 155
BD - Bangladesh 147
JO - Giordania 141
UA - Ucraina 120
NL - Olanda 97
TR - Turchia 90
IQ - Iraq 89
CI - Costa d'Avorio 85
MX - Messico 82
ES - Italia 79
ZA - Sudafrica 69
CH - Svizzera 59
EC - Ecuador 56
BE - Belgio 50
PK - Pakistan 40
NG - Nigeria 36
MA - Marocco 35
CO - Colombia 33
PY - Paraguay 32
VE - Venezuela 29
RO - Romania 28
UZ - Uzbekistan 28
SA - Arabia Saudita 27
AE - Emirati Arabi Uniti 26
PE - Perù 26
CL - Cile 24
EG - Egitto 23
TH - Thailandia 23
TN - Tunisia 22
IR - Iran 20
PH - Filippine 19
IL - Israele 18
AL - Albania 15
AZ - Azerbaigian 15
JM - Giamaica 15
DZ - Algeria 14
AT - Austria 13
LB - Libano 13
PT - Portogallo 13
KE - Kenya 12
BG - Bulgaria 11
LT - Lituania 11
MY - Malesia 11
NP - Nepal 11
CZ - Repubblica Ceca 10
KZ - Kazakistan 10
DO - Repubblica Dominicana 9
HN - Honduras 9
TW - Taiwan 9
BJ - Benin 8
NZ - Nuova Zelanda 8
SK - Slovacchia (Repubblica Slovacca) 8
UY - Uruguay 8
BO - Bolivia 7
DK - Danimarca 7
ET - Etiopia 7
SN - Senegal 7
CR - Costa Rica 6
KG - Kirghizistan 6
LV - Lettonia 6
RS - Serbia 6
BH - Bahrain 5
GR - Grecia 5
OM - Oman 5
QA - Qatar 5
AM - Armenia 4
BB - Barbados 4
GT - Guatemala 4
HR - Croazia 4
KW - Kuwait 4
PS - Palestinian Territory 4
AO - Angola 3
CG - Congo 3
DM - Dominica 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
MU - Mauritius 3
SC - Seychelles 3
SV - El Salvador 3
Totale 61.542
Salva come PNG Salva come JPEG
Città #
Warsaw 10.495
Santa Clara 5.089
Ashburn 3.060
Fairfield 2.212
Singapore 2.207
Hong Kong 1.602
Dublin 1.265
Woodbridge 1.031
Chandler 1.010
Seattle 902
San Jose 866
Seoul 863
Cambridge 826
Houston 787
Wilmington 738
Beijing 621
Florence 515
Council Bluffs 456
Altamura 436
Lawrence 430
Ho Chi Minh City 419
Ann Arbor 405
Hefei 387
The Dalles 369
Princeton 363
Helsinki 304
Lauterbourg 300
Los Angeles 294
Hanoi 284
Moscow 277
Buffalo 268
Mumbai 220
Jakarta 206
New York 205
Dong Ket 198
Medford 193
Boston 190
Dallas 188
San Diego 155
Munich 152
Jacksonville 140
Shanghai 140
Melbourne 138
Boardman 134
Clifton 132
São Paulo 128
Tokyo 127
Kent 108
Paris 108
Phoenix 101
Rome 94
Abidjan 85
Chicago 84
Frankfurt am Main 77
London 77
Falls Church 75
Orem 70
Turku 67
Redondo Beach 62
Guangzhou 58
Rio de Janeiro 57
Norwalk 55
Da Nang 53
Tianjin 53
Haiphong 52
Milan 50
Lappeenranta 49
Toronto 49
Brussels 42
Bern 40
Brooklyn 38
Barcelona 37
Hillsboro 37
Baghdad 36
Chennai 36
Siena 35
Montreal 33
Brasília 31
Amsterdam 30
Biên Hòa 30
Izmir 28
Abuja 27
Curitiba 27
Amman 25
Redwood City 25
Yubileyny 25
Andover 24
Atlanta 24
Johannesburg 24
Salt Lake City 24
San Francisco 24
Shenzhen 24
Belo Horizonte 23
Manchester 23
Tashkent 23
Pune 22
Ribeirão Preto 22
Bengaluru 21
Guayaquil 21
North Bergen 21
Totale 44.113
Salva come PNG Salva come JPEG
Nome #
AG-4:A NICOTINIC AGONIST ENDOWED WITH ANTIAMNESIC PROPERTIES 388
Acute effect of Capparis spinosa root extracts on rat articular pain 375
Effect of the SOD mimetic MnL4 on in vitro and in vivo oxaliplatin toxicity: Possible aid in chemotherapy induced neuropathy 364
A novel manganese complex effective as superoxide anion scavenger and therapeutic agent against cell and tissue oxidative injury. 363
Astragali radix: could it be an adjuvant for oxaliplatin-induced neuropathy? 358
Synthesis of novel cognition enhancer with pyrazolo[5,1-c][1,2,4]benzotriazine core acting at gamma-aminobutyric acid type A (GABAA) receptor. 357
Gc-protein derived macrophage activating factor (GcMAF) counteracts the neuronal damage induced by oxaliplatin 350
α7 Nicotinic Receptor Promotes the Neuroprotective Functions of Astrocytes against Oxaliplatin Neurotoxicity 348
Atomoxetine for hoarding disorder: A pre-clinical and clinical investigation 343
Oxaliplatin Neurotoxicity Involves Peroxisome Alterations. PPARc Agonism as Preventive Pharmacological Approach 342
Local anaesthetic activity of beta-caryophyllene. 335
Aminopyrrolic synthetic receptors for monosaccharides: A class of carbohydrate-binding agents endowed with antibiotic activity versus pathogenic yeasts 332
LOCAL ANAESTHETIC ACTIVITY OF (+) AND (-) MENTHOL 331
Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats 331
Delay of morphine tolerance by palmitoylethanolamide 329
Apoptotic Process Induced by Oxaliplatin in Rat Hippocampus Causes Memory Impairment 320
Involvement of the N/OFQ-NOP system in rat morphine antinociceptive tolerance: Are astrocytes the crossroad? 320
BDNF and ARTEMIN are increased in drug-naïve non-depressed GAD patients: Preliminary data 318
Anti-neuropathic effects of Rosmarinus officinalis L. terpenoid fraction: Relevance of nicotinic receptors 318
Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicity 317
The pharmacological basis of opioids 316
ANTINOCICEPTIVE PROFILE OF THE NATURAL CHOLINESTERASE INHIBITOR HUPERZINE A 313
Adipose-derived stem cells decrease pain in a rat model of oxaliplatin-induced neuropathy: Role of VEGF-A modulation 313
The Role of TRPA1 and TRPV1 Channels in Orofacial Pain 312
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 311
The novel H2S-donor 4-carboxyphenyl isothiocyanate promotes cardioprotective effects against ischemia/reperfusion injury through activation of mitoKATP channels and reduction of oxidative stress 308
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 304
Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy 304
A rat model of FOLFOX-induced neuropathy: effects of oral dimiracetam in comparison with duloxetine and pregabalin 303
Design, Synthesis, and Biological Evaluation of Imidazo[1,5-a]quinoline as Highly Potent Ligands of Central Benzodiazepine Receptors 298
Different apoptotic pathways activated by oxaliplatin in primary astrocytes vs. colo-rectal cancer cells 297
A Series of COX-2 Inhibitors Endowed with NO-Releasing Properties: Synthesis, Biological Evaluation, and Docking Analysis 295
Improving the therapeutic efficacy of prilocaine by PLGA microparticles: Preparation, characterization and in vivo evaluation. 294
Effects of Hypericum perforatum extract on oxaliplatin-induced neurotoxicity: in vitro evaluations 293
Identification of a new pyrazolo[1,5-a]quinazoline ligand highly affine to γ-aminobutyric type A (GABAA) receptor subtype with anxiolytic-like and antihyperalgesic activity 288
Effect of treatment with the antioxidant alpha-lipoic (thioctic) acid on heart and kidney microvasculature in spontaneously hypertensive rats 286
Synthesis and biological evaluation of fluorinated 1,5-diarylpyrrole-3-alkoxyethyl ether derivatives as selective COX-2 inhibitors endowed with anti-inflammatory activity 286
Selective HCN1 block as a strategy to control oxaliplatin-induced neuropathy 286
Brain activity of thioctic Acid enantiomers: in vitro and in vivo studies in an animal model of cerebrovascular injury 284
ANTIAMNESIC EFFECT OF THE TWO NOVEL K-OPIOID AGONISTS, VA-100 AND VA-101, IN THE MOUSE PASSIVE AVOIDANCE TEST 284
Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain 281
Synthesis and Biological Evaluation of Novel Neuroprotective Pyridazine Derivatives as Excitatory Amino Acid Transporter 2 (EAAT2) Activators 281
PPAR-γ Impairment Alters Peroxisome Functionality in Primary Astrocyte Cell Cultures 280
Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin 279
Therapeutic Effects of the Superoxide Dismutase Mimetic Compound Mn(II)Me2DO2A on Experimental Articular Pain in Rats. 277
Astragalus membranaceus and oxaliplatin-induced neuropathy: pain relief and prevention of nervous tissue modifications. 277
Bacopa monnieri as augmentation therapy in the treatment of anhedonia, preclinical and clinical evaluation 277
Effects of a water extract of Lepidium meyenii root in different models of persistent pain in rats 276
Development of solid lipid nanoparticles as carriers for improving oral bioavailability of glibenclamide 276
Neuropathy-induced apoptosis: Protective effect of physostigmine 276
Low dose native type II collagen prevents pain in a rat osteoarthritis model 275
Pretreatment with relaxin does not restore no-mediated modulation of calcium signal in coronary endothelial cells isolated from spontaneously hypertensive rats 272
Pretreatment with Relaxin Does Not Restore NO-Mediated Modulation of Calcium Signal in Coronary Endothelial Cells Isolated from Spontaneously Hypertensive Rats 272
α2 Adrenoceptor: a Target for Neuropathic Pain Treatment 272
Neuroprotective activity of thioctic acid in central nervous system lesions consequent to peripheral nerve injury. 272
Combined Approach of Cyclodextrin Complexation and Nanostructured Lipid Carriers for the Development of a Pediatric Liquid Oral Dosage Form of Hydrochlorothiazide 271
Analgesic and antineuropathic drugs acting through central cholinergic mechanisms 268
Photobiomodulation therapy by NIR laser in persistent pain: an analytical study in the rat 268
Selenium and zinc: Two key players against cadmium-induced neuronal toxicity. 268
Using palmitoylethanolamide in combination with opioids 267
Calcium alginate microspheres containing metformin hydrochloride niosomes and chitosomes aimed for oral therapy of type 2 diabetes mellitus 264
Synthesis, antiarrhythmic activity, and toxicological evaluation of mexiletine analogues 264
Acute visceral pain relief mediated by A(3)AR agonists in rats: involvement of N-type voltage-gated calcium channels 263
GLUTAMATERGIC SYSTEM MODULATORS AS AGENTS IN PREVENTION AND MANAGEMENT OF CHEMOTHERAPY- INDUCED POLYNEUROPATHY 260
Development of ligands at gamma aminobutyrric acid type A (GABAA) receptor subtype as new agent for pain relief. 257
TREATMENT WITH ACETYL-L-CARNITINE EXERTS A NEUROPROTECTIVE EFFECT IN THE SCIATIC NERVE FOLLOWING LOOSE LIGATION: A FUNCTIONAL AND MICROANATOMICAL STUDY 256
Heterocoumarins Are Selective Carbonic Anhydrase IX and XII Inhibitors with Cytotoxic Effects against Cancer Cells Lines 255
Synthesis, biological evaluation and docking analysis of a new series of methylsulfonyl and sulfamoyl acetamides and ethyl acetates as potent COX-2 inhibitors 254
OXALIPLATIN-INDUCED BLOOD BRAIN BARRIER LOOSENING: A NEW POINT OF VIEW ON CHEMOTHERAPY-INDUCED NEUROTOXICITY 253
Effect of glucoraphanin and sulforaphane against chemotherapy-induced neuropathic pain: Kv7 potassium channels modulation by H2 S release in vivo. 249
Palmitoylthanolamide is a disease-modifying agent in peripheral neuropathy: pain relief and neuroprotection share a PPAR-apha-mediated mechanism. 248
Effects of Cadmium on ZO-1 Tight Junction Integrity of the Blood Brain Barrier. 248
Synthesis of five and six-membered heterocycles bearing an arylpiperazinylalkyl side chain as orally active antinociceptive agents 248
Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors 248
RELAXANT EFFECT OF A WATER SOLUBLE CARBON MONOXIDE-RELEASING MOLECULE (CORM-3) ON SPONTANEOUSLY HYPERTENSIVE RAT AORTAS 247
4-Hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms IX and XII showing hypoxia-enhanced anti-proliferative profiles. 247
Tanshinones from Salvia miltiorrhiza Bunge revert chemotherapy-induced neuropathic pain and reduce glioblastoma cells malignancy 246
Effects of natural and synthetic isothiocyanate-based H2S-releasers against chemotherapy-induced neuropathic pain: Role of Kv7 potassium channels 245
Visceral sensitivity modulation by faecal microbiota transplantation: the active role of gut bacteria in pain persistence 244
Pain relieving and protective effects of Astragalus hydroalcoholic extract in rat arthritis models 241
Anticancer properties of erucin, an H2 S-releasing isothiocyanate, on human pancreatic adenocarcinoma cells (AsPC-1). 239
Erucin exhibits vasorelaxing effects and antihypertensive activity by H2 S-releasing properties 234
Lipoyl-Homotaurine Derivative (ADM_12) Reverts Oxaliplatin-Induced Neuropathy and Reduces Cancer Cells Malignancy by Inhibiting Carbonic Anhydrase IX (CAIX) 233
Intestinal inflammation increases convulsant activity and reduces antiepileptic drug efficacy in a mouse model of epilepsy. 232
Synthesis and pharmacological evaluation of novel GABAA subtype receptor ligands with potential anxiolytic-like and anti-hyperlagesic effect 231
Synergic stimulation of serotonin 5-HT1A receptor and α2-adrenoceptors for neuropathic pain relief: Preclinical effects of 2-substituted imidazoline derivatives 229
Prophylactic versus Therapeutic Fingolimod: Restoration of Presynaptic Defects in Mice Suffering from Experimental Autoimmune Encephalomyelitis 228
Cannabidiol protects dopaminergic neuronal cells from cadmium 227
Identification of the First Synthetic Allosteric Modulator of the CB2 Receptors and Evidence of Its Efficacy for Neuropathic Pain Relief 223
Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain 222
Design, Synthesis, and X-ray of Selenides as New Class of Agents for Prevention of Diabetic Cerebrovascular Pathology 222
Coronaridine congeners decrease neuropathic pain in mice and inhibit α9α10 nicotinic acetylcholine receptors and CaV2.2 channels 221
Selective Blockade of HCN1/HCN2 Channels as a Potential Pharmacological Strategy Against Pain 220
Development of Potent Inhibitors of Fatty Acid Amide Hydrolase Useful for the Treatment of Neuropathic Pain 220
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino Derivatives As New Potent and Selective Human A3Adenosine Receptor Antagonists. Molecular Modeling Studies and Pharmacological Evaluation 219
Structural investigations on coumarins leading to chromeno[4,3-c]pyrazol-4-ones and pyrano[4,3-c]pyrazol-4-ones: New scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII 218
3-Hydroxy-1H-quinazoline-2,4-dione as a New Scaffold to Develop Potent and Selective Inhibitors of the Tumor-Associated Carbonic Anhydrases IX and XII 215
Phaseolus vulgaris L. Extract: Alpha-Amylase Inhibition against Metabolic Syndrome in Mice . 214
Blueberry juice protects osteocytes and bone precursor cells against oxidative stress partly through SIRT1 213
Efficacy of a vegetal mixture composed of Zingiber officinale, Echinacea purpurea, and Centella asiatica in a mouse model of neuroinflammation: In vivo and ex vivo analysis 212
Totale 27.808
Salva come PNG Salva come JPEG
Categoria #
all - tutte 162.858
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 162.858
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021550 0 0 0 0 0 0 0 0 0 0 219 331
2021/20222.350 53 165 210 117 74 144 91 187 188 189 310 622
2022/20235.305 540 1.178 254 264 334 929 768 287 469 38 153 91
2023/20242.021 90 218 349 97 138 281 97 355 51 137 138 70
2024/202515.786 527 1.696 1.090 2.242 4.320 2.024 468 820 925 450 613 611
2025/202617.101 1.812 2.317 1.455 2.012 1.917 814 2.149 1.045 1.504 1.303 773 0
Totale 62.237